𝔖 Bobbio Scriptorium
✦   LIBER   ✦

COX-2 expression in thymomas and thymic carcinomas: a novel therapeutic target?

✍ Scribed by RJ Rieker, PhA Schnabel, G Mechtersheimer, M Thomas, H Dienemann…

Book ID
120695321
Publisher
BioMed Central
Year
2007
Tongue
English
Weight
71 KB
Volume
2
Category
Article
ISSN
1746-1596

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

COX-2 upregulation in thymomas and thymi
COX-2 upregulation in thymomas and thymic carcinomas
✍ Ralf J. Rieker; Stefan Joos; Gunhild Mechtersheimer; Hendrik Blaeker; Philipp A. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 289 KB

## Abstract The treatment of advanced stage thymomas and thymic carcinomas is a multimodal therapy. New therapeutic targets are currently under investigation, including the epidermal growth factor receptor (EGFR) as well as KIT. A number of studies have shown protumorigenic potential of Cyclooxygen

Insulin-like growth factor-1 receptor an
Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas
✍ Paolo A. Zucali; Iacopo Petrini; Elena Lorenzi; Maria Merino; Liang Cao; Luca Di 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB

## Abstract ## BACKGROUND: Thymic malignancies are rare tumors. The insulin‐like growth factor‐1 (IGF‐1)/IGF‐1 receptor (IGF‐1R) system is involved in the development of the thymus. IGF‐1R expression in thymic epithelial malignancies is unknown. ## METHODS: The authors investigated the expressio